(Q80984406)
Statements
Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemia (English)
Massimo Breccia
Daniela Diverio
Fabiana Gentilini
Franco Mandelli
Francesco Lo Coco